19PPreclinical drug testing and clinical trial planning of palbociclib (CDK4/6 inhibitor) drug combination with a PI3K or MAPK inhibitor for colorectal cancer (CRC). (27th February 2019) - Lee, C L; Toomey, S; Farrelly, A; Hennessy, B